Pan-cancer immunogenomic analyses have revealed that many TILs related to adaptive immunity are associated with a good prognosis, including activated CD8+ T cells, effector memory T cells and central memory CD8+ T cells, and effector memory CD4+ T cells, whereas MDSCs and Tregs are associated with a poor prognosis9. This evidence concerns the gene CD8A and cancer.